Monitor for future filings (10-Q, 10-K) to assess audit quality and financial reporting consistency under new auditor. The lack of full concurrence from Deloitte warrants caution despite clean audit history.
Price Chart
Executive Summary
Instil Bio, Inc. (TIL) dismissed Deloitte & Touche LLP as its independent auditor and appointed RSM US LLP effective April 1, 2026. Deloitte confirmed no disagreements or reportable events, but its letter indicates it cannot confirm the dismissal was not due to disagreements, raising caution.
Key Facts
- Deloitte & Touche LLP was dismissed as auditor; RSM US LLP was appointed.
- Deloitte's audit reports for 2024 and 2025 had no adverse opinions or qualifications.
- No disagreements or reportable events were disclosed with Deloitte.
- Deloitte's letter states it has no basis to agree or disagree with the dismissal reason, which may suggest undisclosed issues.
- Company is an emerging growth company with no extended transition period election.
Financial Impact
No direct financial impact disclosed; change in auditor may signal internal shifts but no material weaknesses reported.
Risk Factors
- Potential undisclosed disagreements with former auditor despite clean audit opinions.
- Risk of future material weaknesses or restatements under new auditor RSM.
- Market perception of auditor change as a red flag, especially for a small-cap biotech with limited financial disclosures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001789769-26-000024 |
| Document: seccessationofclient-audit.htm | 0001789769-26-000024 |
| Document: 0001789769-26-000024-index-headers.html | 0001789769-26-000024 |
| Document: 0001789769-26-000024-index.html | 0001789769-26-000024 |
| Document: 0001789769-26-000024.txt | 0001789769-26-000024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Press Release | $7.38 $7.45 | ▲ +0.95% | ▲ +2.94% | $7.34 (−0.54%) |
Aug 13, 2026 7w ago | 8-K | $7.38 $7.45 | ▲ +0.95% | ▲ +2.94% | $7.34 (−0.54%) |
May 15, 2026 20w ago | 8-K | $8.07 $7.92 | ▼ −1.86% | ▼ −3.98% | $7.34 (−9.05%) |
May 15, 2026 20w ago | Press Release | $8.07 $7.92 | ▼ −1.86% | ▼ −3.98% | $7.34 (−9.05%) |
Apr 24, 2026 22w ago | DEFA14A | $8.13 $8.12 | ▼ −0.12% | ▼ −5.08% | $7.34 (−9.72%) |
Apr 3, 2026 26w ago | 8-K | $8.46 $7.84 | ▼ −7.33% | ▼ −16.31% | $7.34 (−13.24%) |
Mar 27, 2026 27w ago | Press Release | $7.79 $8.13 | ▲ +4.36% | ▼ −8.38% | $7.34 (−5.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access